Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

  title={Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment},
  author={Carmine Maria Pariante and Andrew H. Miller},
  journal={Biological Psychiatry},

Figures and Tables from this paper

Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders

Evidence is presented suggesting that membrane steroid transporters such as the multidrug resistance p-glycoprotein, which regulate access of glucocorticoids to the brain, could be a fundamental target of antidepressant treatment.

The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?

The glucocorticoid receptor: part of the solution or part of the problem?

  • C. Pariante
  • Biology, Psychology
    Journal of psychopharmacology
  • 2006
It is concluded that a lack of the ‘positive’ effects of cortisol on the brain, because of glucocorticoid resistance, is likely to be involved in the pathogenesis of depression.

Glucocorticoid Receptor Function In Vitro in Patients with Major Depression

In vitro studies are of particular relevance to understand the molecular mechanisms underlying GR abnormalities in patients with major depression and its regulation by antidepressant treatment, according to this review.

Glucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders

HPA axis dysfunction is prevalent in patients with mood disorder, particularly those with psychotic disorders and bipolar affective disorder, and preliminary findings suggest that it is a potential target for novel therapies.

Risk Factors for Development of Depression and Psychosis

  • C. Pariante
  • Biology, Psychology
    Annals of the New York Academy of Sciences
  • 2009
Clinical and experimental studies do not support the notion that “high levels of glucocorticoids” always have a depressogenic effect, nor that decreasing the effects of these hormones always has an antidepressant effects.

The glucocorticoid hypothesis of depression: History and prospects

The purpose of this review was to analyze the available published data on the effects of stress and glucocorticoids on the expression of GRs in the hippocampus, which is traditionally considered as the most sensitive to stress brain structure, and the implication of the interplay ofGRs and BDNF in the pathogenesis of stress-related disorders.

In vitro modulation of the glucocorticoid receptor by antidepressants

The in vitro studies that have examined the effect of antidepressants on GR expression, number and function in human and animal cell lines are reviewed, and the possible molecular mechanisms underlying these effects are reviewed.

Polymorphisms of the Glucocorticoid Receptor Gene and Major Depression




Glucocorticoid receptors in depression.

Amid intriguing data indicating monoamine regulation of GR number and function in a hormone independent fashion along with the well-known effects of glucocorticoids on behavior, further scrutiny of the role of GR in depression and its treatment is warranted.

Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine

It is suggested that one important aspect of the effects of antidepressants in vivo may be to facilitate GR-mediated feedback inhibition on the HPA axis, by facilitating GR translocation and function, and thereby reverse glucocorticoid hypersecretion in depression.

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression.

Findings suggest that factors which modulate glucocorticoid action (e.g. cytokines and antidepressants) will be relevant contributors to disease expression including behavioral toxicity and sickness behavior.

Long‐Term Treatment with Antidepressants Increases Glucocorticoid Receptor Binding and Gene Expression in Cultured Rat Hippocampal Neurones

It is suggested that tricyclic antidepressants directly increase hippocampal GR by short‐term and long-term exposure, and that the increase by long‐term exposure is evoked commonly with different classes of antidepressants through transcriptional up‐regulation of GR expression.

Antidepressants and hypothalamic-pituitary-adrenocortical regulation.

It is shown that antidepressants interfere not only with the production and release of catecholamines and indolamines but also with the signal transduction of those neurotransmitters that have long been implicated in the pathogenesis and treatment of depression.

Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone.